The Evaluation of Cow's Milk Formula - Study B

NCT ID: NCT00712608

Last Updated: 2010-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

399 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-08-31

Study Completion Date

2009-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study to evaluate the growth and development of term infants fed either a marketed cow's milk formula, or an experimental cow's milk formula with prebiotics + a different calcium source + a different level of fatty acids and fat, or an experimental cow's milk formula with prebiotic + a different calcium source + a different level of fatty acids and fat

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Term Infants

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Term Infant Formula

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Marketed cow's milk-based formula

Group Type ACTIVE_COMPARATOR

Infant formula

Intervention Type OTHER

Marketed cow's milk base infant formula 20 kcal/oz

2

Cow's milk based formula with prebiotics, different level of fatty acids and fat and a different calcium source

Group Type EXPERIMENTAL

Infant formula

Intervention Type OTHER

cow's milk based infant formula with prebiotics, different level of fatty acids and fat and a different calcium source

3

Cow's milk based formula with prebiotic, different level of fatty acids and fat and a different calcium source

Group Type EXPERIMENTAL

Cow's milk infant formula

Intervention Type OTHER

Cow's milk based formula with prebiotics, different level of fatty acids and fat and a different calcium source

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Infant formula

Marketed cow's milk base infant formula 20 kcal/oz

Intervention Type OTHER

Infant formula

cow's milk based infant formula with prebiotics, different level of fatty acids and fat and a different calcium source

Intervention Type OTHER

Cow's milk infant formula

Cow's milk based formula with prebiotics, different level of fatty acids and fat and a different calcium source

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Similar to Enfamil LIPIL with iron No other similar brand names; experimental formula No other similar brand names; experimental product

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Term infant
* 12-16 days of age
* 37-42 weeks GA

Exclusion Criteria

* History of chronic disease, congenital malformation
* Feeding difficulties or formula intolerance
* LGA
Minimum Eligible Age

12 Days

Maximum Eligible Age

16 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mead Johnson Nutrition

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mead Johnson & Company

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carol L Berseth, MD

Role: STUDY_DIRECTOR

Mead Johnson & Company

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birmingham Pediatric Group

Birmingham, Alabama, United States

Site Status

Alabama Clinical Therapeutics

Dothan, Alabama, United States

Site Status

Central Arkansas Pediatric Clinic

Benton, Arkansas, United States

Site Status

Medical Associates

Fayetteville, Arkansas, United States

Site Status

Arkansas Children's Hospital Research Institute

Little Rock, Arkansas, United States

Site Status

Arkansas Pediatric Clinic

Little Rock, Arkansas, United States

Site Status

Norwich Pediatric Group, PC

Norwich, Connecticut, United States

Site Status

Palm Beach Clinical Investigation, LLC

West Palm Beach, Florida, United States

Site Status

Welborn Clinic Research

Newburgh, Indiana, United States

Site Status

Woburn Pediatric Associates Research Department

Woburn, Massachusetts, United States

Site Status

Southwestern Medical Clinic, PC

Niles, Michigan, United States

Site Status

Southwestern Medical Clinic, PC

Stevensville, Michigan, United States

Site Status

Aspen Medical Group

Saint Paul, Minnesota, United States

Site Status

The Center for Human Nutrition

Omaha, Nebraska, United States

Site Status

Odyssey Research

Minot, North Dakota, United States

Site Status

Red Lion Pediatrics

Philadelphia, Pennsylvania, United States

Site Status

Primary Physicians Research, Inc

Pittsburgh, Pennsylvania, United States

Site Status

Holston Medical Group, MeadowView Lane

Kingsport, Tennessee, United States

Site Status

Holston Medical Group

Kingsport, Tennessee, United States

Site Status

Retina Foundation of the Southwest

Dallas, Texas, United States

Site Status

DCOL Center for Clinical Research

Longview, Texas, United States

Site Status

Texas Tech University Health Sciences Center

Lubbock, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Ashley C, Johnston WH, Harris CL, Stolz SI, Wampler JL, Berseth CL. Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial. Nutr J. 2012 Jun 7;11:38. doi: 10.1186/1475-2891-11-38.

Reference Type DERIVED
PMID: 22676715 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3378-2

Identifier Type: -

Identifier Source: org_study_id